RxDoctor Payments Data

Laura Johnson, MD

Surgery · Atlanta, GANPI 1407014319

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,531 of the $9,114 with a category attached, or 71.7%. Smith+Nephew accounts for 84.3% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $6,721, more than ten times the $15 reported in 2020.

$9,114in general payments, 2019–2025

Across 34 payments — averaging $268.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$8K
  • Polymedics Innovations Inc.$853
  • Polynovo North America LLC$336
  • Medtronic$162
  • ETS Wound Care LLC$29
  • Medline Industries LP$20
  • plus $33 from 2 others
$106,678in research payments, 2019–2025

Across 70 payments — averaging $1523.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Polynovo North America LLC$82K
  • Polarityte, Inc.$25K

What the payments were for

  • Consulting fees$6,53172%
  • Travel & lodging$8269%
  • Food & beverage$1,67618%
  • Education$801%

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew10$7,681
Polymedics Innovations Inc.16$853
Polynovo North America LLC3$336
Medtronic1$162
ETS Wound Care LLC1$29
Medline Industries LP1$20
Ambu Inc.1$18
AbbVie1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,114 in reported general payments places this provider in the 80th percentile of 855 surgery providers in Georgia.

See all surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$31,354
Medicare patients
20
Services billed
295

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin32$331
Mupirocin12$171
Oxycodone Hcl46$152

Paid to pharmacies, not to this prescriber.

Other surgery in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →